Primer-Introduced Restriction Analysis Polymerase Chain Reaction Method for Non-Invasive Prenatal Testing ofβ-Thalassemia

Authors:
  • LCLiyuan Chen
    Liyuan Chen
  • XZXiandong Zhang
    Xiandong Zhang
  • JLJian Li
    Jian Li
  • HLHaiying Lin
    Haiying Lin
  • LLLouhui Liu
    Louhui Liu
  • HGHuijuan Ge
    Huijuan Ge
  • MYMinglan Ye
    Minglan Ye
  • CCCaifen Chen
    Caifen Chen
  • XJXingwen Ji
    Xingwen Ji
  • CZCaifen Zhang
    Caifen Zhang

Abstract
We have developed a new method for non-invasive prenatal testing (NIPT) of paternally inherited fetal mutants for β-thalassemia (β-thal). Specially designed primer-introduced restriction analysis-polymerase chain reaction (PIRA-PCR) were used to detect four major mutations [IVS-II-654, HBB: c.316-197C > T; codon 17 (A > T), HBB: c.52A > T; -28 (A > G), HBB: c.-78A > G and codons 41/42 (-TTCT), HBB: c.126_129delCTTT] causing β-thal in China. The PIRA-PCR assay was first tested in a series of mixed DNA with different concentrations and mixed proportions. Subsequently, this assay was further tested in 10 plasma DNA samples collected from pregnant women. In the DNA mixture simulation test, the PIRA-PCR assay was able to detect 3.0% target genomic DNA (gDNA) mixed in 97.0% wild-type gDNA isolated from whole blood. For plasma DNA testing, the results detected by PIRA-PCR assay achieved 100.0% consistency with those obtained from the amniocentesis analysis. This new method could potentially be used for NIPT of paternally inherited fetal mutants for β-thal.

This publication has 20 references indexed in Scilit: